Secondary Prevention in Hereditary Breast and/or Ovarian Cancer Syndromes Other Than BRCA.


Journal

Journal of oncology
ISSN: 1687-8450
Titre abrégé: J Oncol
Pays: Egypt
ID NLM: 101496537

Informations de publication

Date de publication:
2020
Historique:
received: 04 03 2020
accepted: 16 06 2020
entrez: 1 8 2020
pubmed: 1 8 2020
medline: 1 8 2020
Statut: epublish

Résumé

BRCA1- and BRCA2-associated hereditary breast and ovarian cancer syndromes are among the best-known and most extensively studied hereditary cancer syndromes. Nevertheless, many patients who proved negative at BRCA genetic testing bring pathogenic mutations in other suppressor genes and oncogenes associated with hereditary breast and/or ovarian cancers. These genes include

Identifiants

pubmed: 32733558
doi: 10.1155/2020/6384190
pmc: PMC7376433
doi:

Types de publication

Journal Article Review

Langues

eng

Pagination

6384190

Informations de copyright

Copyright © 2020 Claudia Piombino et al.

Déclaration de conflit d'intérêts

The authors declare that they have no conflicts of interest.

Références

Cancer. 2016 Dec 1;122(23):3673-3681
pubmed: 27496084
Gynecol Oncol. 2019 May;153(2):452-462
pubmed: 30733081
JCO Precis Oncol. 2018;2:
pubmed: 31517176
Am J Gastroenterol. 2015 Feb;110(2):223-62; quiz 263
pubmed: 25645574
Radiat Oncol. 2010 Nov 08;5:104
pubmed: 21059199
J Med Genet. 2017 Nov;54(11):742-746
pubmed: 28779004
Gut. 2002 Oct;51 Suppl 5:V21-7
pubmed: 12221036
Pediatrics. 2019 May;143(5):
pubmed: 31010905
J Clin Oncol. 2015 Jan 10;33(2):209-17
pubmed: 25452455
Am J Hum Genet. 2004 Dec;75(6):1131-5
pubmed: 15492928
Nat Rev Clin Oncol. 2016 Sep;13(9):581-8
pubmed: 27296296
JAMA Oncol. 2019 Jan 1;5(1):51-57
pubmed: 30128536
Scand J Gastroenterol. 2002 May;37(5):574-7
pubmed: 12059060
Orphanet J Rare Dis. 2012 Feb 28;7:13
pubmed: 22373003
Gastrointest Endosc. 2014 Jul;80(1):78-87
pubmed: 24472763
Science. 2009 Apr 10;324(5924):217
pubmed: 19264984
Fam Cancer. 2013 Jun;12(2):267-72
pubmed: 23420551
JAMA Oncol. 2017 Dec 1;3(12):1634-1639
pubmed: 28772291
Genet Epidemiol. 2016 Jul;40(5):425-31
pubmed: 27112364
DNA Repair (Amst). 2004 Aug-Sep;3(8-9):1187-96
pubmed: 15279807
Cancer Res. 2011 Mar 15;71(6):2222-9
pubmed: 21285249
J Med Genet. 2004 May;41(5):323-6
pubmed: 15121767
Lancet Oncol. 2011 Jan;12(1):49-55
pubmed: 21145788
J Clin Oncol. 2008 Feb 1;26(4):542-8
pubmed: 18172190
Fam Cancer. 2013 Jun;12(2):313-7
pubmed: 23568035
N Engl J Med. 2014 Aug 7;371(6):497-506
pubmed: 25099575
Clin Gastroenterol Hepatol. 2020 Apr;18(4):830-837.e1
pubmed: 31319185
Cancer. 2017 Oct 15;123(20):3925-3932
pubmed: 28657667
Clin Cancer Res. 2012 Jan 15;18(2):400-7
pubmed: 22252256
Gastroenterology. 2010 Dec;139(6):1927-33
pubmed: 20600018
JAMA Oncol. 2017 Sep 1;3(9):1190-1196
pubmed: 28418444
J Natl Cancer Inst. 2007 Dec 19;99(24):1875-80
pubmed: 18073374
Cold Spring Harb Perspect Med. 2017 Apr 3;7(4):
pubmed: 28270529
Gastric Cancer. 2012 Sep;15 Suppl 1:S153-63
pubmed: 22160243
Int J Cancer. 2019 Mar 1;144(5):1001-1009
pubmed: 30098212
World J Gastrointest Oncol. 2015 Sep 15;7(9):153-60
pubmed: 26380059
N Engl J Med. 2006 Jan 19;354(3):261-9
pubmed: 16421367
Lancet Oncol. 2016 Sep;17(9):1295-305
pubmed: 27501770
Breast Cancer Res. 2019 Apr 29;21(1):55
pubmed: 31036035
Gut. 2017 Mar;66(3):464-472
pubmed: 26657901
J Genet Couns. 2009 Feb;18(1):13-27
pubmed: 18972196
Genet Med. 2018 Oct;20(10):1167-1174
pubmed: 29345684
Gut. 2013 Jun;62(6):812-23
pubmed: 23408351
Gastroenterology. 2010 Jun;138(6):2073-2087.e3
pubmed: 20420947
Gut. 2013 Mar;62(3):339-47
pubmed: 23135763
Cancers (Basel). 2019 May 28;11(6):
pubmed: 31142030
Clin Cancer Res. 2017 Jun 1;23(11):e38-e45
pubmed: 28572266
Am J Med Genet A. 2012 Dec;158A(12):3054-5
pubmed: 22987630
J Med Genet. 2015 Aug;52(8):553-6
pubmed: 26101330
Cancers (Basel). 2019 Feb 07;11(2):
pubmed: 30736435
Breast J. 2013 Jan-Feb;19(1):10-21
pubmed: 23252601
Breast Cancer Res. 2015 Jul 11;17:94
pubmed: 26163296
Genet Med. 2009 Oct;11(10):687-94
pubmed: 19668082
Oncology. 2017;93(6):377-386
pubmed: 28848147
Genet Med. 2018 Jul;20(7):671-682
pubmed: 30006586
Cancer Res. 2020 Feb 1;80(3):624-638
pubmed: 31723001
J Clin Oncol. 2011 Oct 1;29(28):3747-52
pubmed: 21876083
Science. 1994 Sep 30;265(5181):2088-90
pubmed: 8091231
Eur J Contracept Reprod Health Care. 2019 Dec;24(6):417-419
pubmed: 31361161
Science. 1990 Dec 21;250(4988):1684-9
pubmed: 2270482
JAMA. 2007 Jun 6;297(21):2360-72
pubmed: 17545690
Br J Cancer. 2015 Apr 28;112(9):1546-8
pubmed: 25742481
Oncotarget. 2017 Feb 7;8(6):9144-9154
pubmed: 27880720
J Natl Cancer Inst. 2013 Nov 6;105(21):1607-16
pubmed: 24136893
J Clin Oncol. 2017 Oct 20;35(30):3382-3390
pubmed: 28767289
J Clin Oncol. 2005 Jan 10;23(2):276-92
pubmed: 15637391
Genet Med. 2014 Jul;16(7):553-7
pubmed: 24434690
Lancet Oncol. 2011 Jun;12(6):559-67
pubmed: 21601526
Am J Gastroenterol. 2014 Aug;109(8):1159-79
pubmed: 25070057

Auteurs

Claudia Piombino (C)

Department of Oncology and Hematology, University Hospital of Modena, Modena, Italy.

Laura Cortesi (L)

Department of Oncology and Hematology, University Hospital of Modena, Modena, Italy.

Matteo Lambertini (M)

Department of Medical Oncology, U.O.C Clinica di Oncologia Medica, IRCCS Ospedale Policlinico San Martino, Genova, Italy.
Department of Internal Medicine and Medical Specialties (DiMI), School of Medicine, University of Genova, Genova, Italy.

Kevin Punie (K)

Department of General Medical Oncology, Multidisciplinary Breast Center, Leuven Kanker Instituut, University Hospitals Leuven, Leuven, Belgium.

Giovanni Grandi (G)

Department of Obstetrics and Ginecology, University Hospital of Modena, Modena, Italy.

Angela Toss (A)

Department of Oncology and Hematology, University Hospital of Modena, Modena, Italy.
Department of Surgery, Medicine, Dentistry and Morphological Sciences with Transplant Surgery, Oncology and Regenerative Medicine Relevance, University of Modena and Reggio Emilia, Modena, Italy.

Classifications MeSH